Uncategorized

Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease – Fortune

  1. Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease  Fortune
  2. Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature.com
  3. Sweeping review suggests weight-loss drugs’ effect on 175 conditions  The Washington Post
  4. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  5. Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind  Livescience.com